Kimberly-Clark (NYSE:KMB) Price Target Raised to $142.00 at JPMorgan Chase & Co.

Kimberly-Clark (NYSE:KMB) had its price objective upped by investment analysts at JPMorgan Chase & Co. from $137.00 to $142.00 in a note issued to investors on Friday, Benzinga reports. The firm presently has an “underweight” rating on the stock. JPMorgan Chase & Co.‘s price objective would suggest a potential upside of 0.37% from the stock’s previous close.

Other equities research analysts have also issued research reports about the company. Barclays dropped their price objective on Kimberly-Clark from $136.00 to $135.00 and set an “equal weight” rating for the company in a research note on Friday, July 19th. Argus upgraded shares of Kimberly-Clark to a “hold” rating in a research report on Friday, July 26th. Piper Sandler raised their target price on shares of Kimberly-Clark from $167.00 to $174.00 and gave the company an “overweight” rating in a research note on Thursday, July 11th. Bank of America raised shares of Kimberly-Clark from an “underperform” rating to a “buy” rating and boosted their price target for the stock from $115.00 to $160.00 in a research note on Thursday, June 13th. Finally, BNP Paribas initiated coverage on shares of Kimberly-Clark in a research report on Monday, June 24th. They set a “neutral” rating and a $146.00 price objective on the stock. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $146.47.

Kimberly-Clark Price Performance

NYSE KMB traded up $0.42 during trading hours on Friday, hitting $141.48. The company had a trading volume of 132,125 shares, compared to its average volume of 2,095,369. The company has a debt-to-equity ratio of 5.59, a quick ratio of 0.58 and a current ratio of 0.85. The firm has a market capitalization of $47.65 billion, a price-to-earnings ratio of 20.92, a PEG ratio of 2.98 and a beta of 0.39. Kimberly-Clark has a 52 week low of $116.63 and a 52 week high of $149.30. The firm has a 50 day simple moving average of $142.55 and a 200 day simple moving average of $137.59.

Kimberly-Clark (NYSE:KMB) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $1.96 EPS for the quarter, beating the consensus estimate of $1.71 by $0.25. Kimberly-Clark had a net margin of 11.28% and a return on equity of 223.55%. The company had revenue of $5.03 billion during the quarter, compared to analysts’ expectations of $5.10 billion. During the same quarter in the previous year, the company earned $1.65 earnings per share. Kimberly-Clark’s revenue for the quarter was down 2.0% on a year-over-year basis. Equities research analysts expect that Kimberly-Clark will post 7.25 earnings per share for the current year.

Insider Buying and Selling at Kimberly-Clark

In other Kimberly-Clark news, insider Gonzalo Uribe sold 1,780 shares of the business’s stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $140.84, for a total value of $250,695.20. Following the transaction, the insider now owns 7,377 shares in the company, valued at approximately $1,038,976.68. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, insider Jeffrey P. Melucci sold 37,699 shares of the business’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $141.42, for a total transaction of $5,331,392.58. Following the transaction, the insider now directly owns 19,935 shares of the company’s stock, valued at approximately $2,819,207.70. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Gonzalo Uribe sold 1,780 shares of the firm’s stock in a transaction on Monday, July 29th. The stock was sold at an average price of $140.84, for a total value of $250,695.20. Following the completion of the sale, the insider now directly owns 7,377 shares of the company’s stock, valued at $1,038,976.68. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.62% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the stock. CX Institutional boosted its position in Kimberly-Clark by 1.2% during the 2nd quarter. CX Institutional now owns 5,968 shares of the company’s stock valued at $825,000 after acquiring an additional 71 shares in the last quarter. Capital Investment Counsel Inc lifted its position in Kimberly-Clark by 0.8% during the 1st quarter. Capital Investment Counsel Inc now owns 10,019 shares of the company’s stock valued at $1,296,000 after acquiring an additional 75 shares during the period. Connecticut Wealth Management LLC boosted its stake in Kimberly-Clark by 4.6% during the first quarter. Connecticut Wealth Management LLC now owns 1,755 shares of the company’s stock worth $227,000 after acquiring an additional 77 shares in the last quarter. Equitable Trust Co. grew its holdings in Kimberly-Clark by 0.9% in the second quarter. Equitable Trust Co. now owns 9,066 shares of the company’s stock worth $1,253,000 after purchasing an additional 80 shares during the period. Finally, Comprehensive Financial Consultants Institutional Inc. increased its stake in shares of Kimberly-Clark by 1.6% during the first quarter. Comprehensive Financial Consultants Institutional Inc. now owns 5,093 shares of the company’s stock valued at $659,000 after purchasing an additional 81 shares in the last quarter. 76.29% of the stock is currently owned by institutional investors.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.